Clinical Trial

Effect of Different Hyaluronic Acids in the Treatment of Subdeltoid Bursitis

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The study employs a double-blind, randomized clinical trial design with 50 patients diagnosed with subdeltoid bursitis. Participants are divided into two groups: ultra-high-molecular-weight hyaluronic acid or high-molecular-weight hyaluronic acid injection. All injections are guided by ultrasound. Assessments are conducted before treatment and at 1 week, 1 month, and 3 months post-treatment.
Trial Details
NCT Number NCT07729514
Lead Sponsor Shin Kong Wu Ho-Su Memorial Hospital
Conditions Subdeltoid Bursitis of the Shoulder
Enrollment 52 participants
Start Date 2026-08-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-30